An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Gilead Sciences, Inc. (Nasdaq: GILD) executives will be speaking at several upcoming investor conferences, showcasing the company's commitment to advancing innovative medicines for life-threatening diseases such as HIV, viral hepatitis, COVID-19, and cancer. The live webcasts and replays will be available on the company's investors page. Gilead operates globally with headquarters in Foster City, California.
I dirigenti di Gilead Sciences, Inc. (Nasdaq: GILD) parteciperanno a diverse conferenze per investitori, dimostrando l'impegno dell'azienda nello sviluppo di medicinali innovativi per malattie gravi come l'HIV, l'epatite virale, il COVID-19 e il cancro. Le trasmissioni in diretta e le registrazioni saranno disponibili sulla pagina degli investitori dell'azienda. Gilead ha la sede globale a Foster City, California.
Ejecutivos de Gilead Sciences, Inc. (Nasdaq: GILD) hablarán en varias conferencias de inversionistas próximas, mostrando el compromiso de la compañía con el avance en medicinas innovadoras para enfermedades que amenazan la vida como el VIH, hepatitis viral, COVID-19 y cáncer. Las transmisiones en vivo y las repeticiones estarán disponibles en la página de inversores de la empresa. Gilead opera globalmente con su sede en Foster City, California.
Gilead Sciences, Inc.(나스닥: GILD)의 경영진은 여러 투자자 콘퍼런스에 참여할 예정이며, 이는 회사가 HIV, 바이러스성 간염, COVID-19 및 암과 같은 생명을 위협하는 질병에 대한 혁신적인 의약품 개발에 전념하고 있음을 보여줍니다. 생중계 및 재방송은 회사의 투자자 페이지에서 볼 수 있습니다. Gilead의 본사는 캘리포니아 포스터 시티에 위치하고 있습니다.
Les dirigeants de Gilead Sciences, Inc. (Nasdaq: GILD) prendront la parole lors de plusieurs conférences d'investisseurs à venir, démontrant l'engagement de l'entreprise dans le développement de médicaments innovants pour des maladies menaçantes telles que le VIH, l'hépatite virale, le COVID-19 et le cancer. Les webdiffusions en direct et les rediffusions seront disponibles sur la page des investisseurs de l'entreprise. Gilead opère globalement avec son siège à Foster City, en Californie.
Führungskräfte von Gilead Sciences, Inc. (Nasdaq: GILD) werden auf mehreren bevorstehenden Investorenkonferenzen sprechen, um das Engagement des Unternehmens für die Entwicklung innovativer Medikamente gegen lebensbedrohliche Krankheiten wie HIV, virale Hepatitis, COVID-19 und Krebs zu zeigen. Die Live-Webcasts und Wiederholungen sind auf der Investorenseite des Unternehmens verfügbar. Gilead hat seinen globalen Hauptsitz in Foster City, Kalifornien.
Positive
Gilead Sciences showcasing commitment to advancing innovative medicines for life-threatening diseases.
Executives speaking at prestigious investor conferences to highlight company's achievements.
Global operations in over 35 countries demonstrate strong presence in the biopharmaceutical industry.
Negative
None.
FOSTER CITY, Calif.--(BUSINESS WIRE)--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
BofA Securities Health Care Conference on Tuesday, May 14 at 11:20am Pacific Time
RBCCM Global Healthcare Conference on Wednesday, May 15 at 10:30am Eastern Time
Jefferies Global Healthcare Conference on Wednesday, June 5 at 11:00am Eastern Time
Goldman Sachs Annual Global Healthcare Conference on Wednesday, June 12 at 1:20pm Eastern Time
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
When are Gilead Sciences executives speaking at the BofA Securities Health Care Conference?
Gilead Sciences executives will be speaking at the BofA Securities Health Care Conference on Tuesday, May 14 at 11:20am Pacific Time.
Where can the live webcasts be accessed for Gilead Sciences investor conferences?
The live webcasts for Gilead Sciences investor conferences can be accessed on the company’s investors page at investors.gilead.com.
What is the goal of Gilead Sciences as a biopharmaceutical company?
Gilead Sciences aims to advance innovative medicines to prevent and treat life-threatening diseases such as HIV, viral hepatitis, COVID-19, and cancer.
